Skip to main content

Gerald Bloomfield

Associate Professor of Medicine
Medicine, Cardiology
Department of Medicine, DUMC Box 3850, Durham, NC 27705
300 West Morgan Street, Durham, NC 27701

Overview


Gerald Bloomfield, MD, MPH, joined the faculty in Medicine and Global Health after completing his Cardiovascular Medicine fellowship training at Duke University Medical Center and Duke Clinical Research Institute. Bloomfield also completed the Duke Global Health Residency/Fellowship Pathway and a Fogarty International Clinical Research Fellowship. He received his medical education, internal medicine residency and Master of Public Health degree from Johns Hopkins University. Bloomfield leads a longstanding research and capacity building program on cardiovascular global health which includes work in under-resourced communities in the US and a number of low- and middle-income country settings.

Current Appointments & Affiliations


Associate Professor of Medicine · 2021 - Present Medicine, Cardiology, Medicine
Associate Director for Research at Duke Global Health Institute · 2023 - Present Duke Global Health Institute, University Institutes and Centers
Associate Research Professor of Global Health · 2021 - Present Duke Global Health Institute, University Institutes and Centers
Member in the Duke Clinical Research Institute · 2011 - Present Duke Clinical Research Institute, Institutes and Centers

Recent Publications


Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV.

Journal Article Am Heart J · July 2026 BACKGROUND: People living with HIV experience accelerated aging, increasing their risk of age-related diseases. Chronic inflammation may play an important role in premature vascular aging and myocardial fibrosis, leading to cardiac dysfunction. METHODS: We ... Full text Link to item Cite

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.

Journal Article Lancet HIV · May 2026 BACKGROUND: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) found a 36% reduction in major adverse cardiovascular events (MACE) with pitavastatin in people with HIV. Little is known about the relationship between lipid lowering and MACE i ... Full text Link to item Cite

m-Lifestyle Intervention for Employees (m-LIfE): protocol for a pilot cluster randomized controlled trial on cardiovascular disease prevention strategies.

Journal Article Pilot Feasibility Stud · April 7, 2026 INTRODUCTION: Cardiovascular diseases (CVDs) are the leading cause of mortality globally. Developing countries, including Pakistan, face a significant burden of CVD risk factors. Mobile health (mHealth) interventions have shown potential in promoting physi ... Full text Link to item Cite
View All Publications

Recent Grants


Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030

Cardiac function and proteomic biomarkers in individuals with perinatal HIV infection or exposure

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030

View All Grants

Education


Johns Hopkins University, School of Medicine · 2002 M.D.